{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:03:26Z","timestamp":1772676206167,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Daiwa Securities Foundation"},{"name":"Research Committee on Disorders of Adrenal Hormones"},{"name":"Ministry of Health, Labour, and Welfare of Japan","award":["23FC1041"],"award-info":[{"award-number":["23FC1041"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Primary aldosteronism (PA) adversely affects cardiovascular and renal health and has been linked to increased urinary calcium excretion, elevated parathyroid hormone (PTH) levels, and reduced bone mineral density. Although adrenalectomy and mineralocorticoid receptor antagonists (MRAs) are established treatments, their differential effects on calcium dynamics across PA subtypes remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We conducted a retrospective observational study, analyzing a large, well-characterized cohort on calcium metabolism in PA. A total of 352 patients with PA and 57 controls were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical and biochemical parameters, including intact PTH (iPTH) and urinary electrolyte levels, were retrospectively assessed. Comparative analyses were performed before and after treatment in 43 patients with unilateral PA (UPA) and 131 patients with bilateral PA (BPA), with a direct comparison of adrenalectomy and MRAs in UPA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with PA had higher urinary fractional excretion of calcium (FECa) (1.28% vs 1.04%, P &amp;lt; .001) and iPTH (60.0 vs 57.0\u2005pg\/mL, P = .047) than controls, with more pronounced abnormalities in UPA (FECa, 1.50%, iPTH 73.1\u2005pg\/mL). Both treatments reduced FECa and iPTH levels, but adrenalectomy resulted in greater improvement than MRAs in the UPA (FECa, 0.68% post-MRA vs 0.36% post-adrenalectomy). In the BPA group, MRAs decreased FECa, irrespective of disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adrenalectomy was associated with greater improvements in calcium abnormalities than MRAs in patients with UPA, consistent with its cardiovascular benefits. These findings underscore the importance of subtype-specific strategies and suggest that adrenalectomy may offer additional benefits beyond cardiovascular outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag035","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:55:37Z","timestamp":1771505737000},"page":"275-284","source":"Crossref","is-referenced-by-count":0,"title":["Subtype- and treatment-based analysis of calcium dynamics in primary aldosteronism"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-7028","authenticated-orcid":false,"given":"Toshifumi","family":"Nakamura","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, School of Medicine, Keio University , Tokyo, 160-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, School of Medicine, Keio University , Tokyo, 160-8582 ,","place":["Japan"]},{"name":"Medical Education and Clinical Training Center, National Defense Medical College , Saitama, 359-8513 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, School of Medicine, Keio University , Tokyo, 160-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Kinouchi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, School of Medicine, Keio University , Tokyo, 160-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, School of Medicine, Keio University , Tokyo, 160-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, School of Medicine, Keio University , Tokyo, 160-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"3","key":"2026030420412970400_lvag035-B1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026030420412970400_lvag035-B2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026030420412970400_lvag035-B3","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026030420412970400_lvag035-B4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"issue":"8","key":"2026030420412970400_lvag035-B5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2026030420412970400_lvag035-B6","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/HJH.0000000000000464","article-title":"Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness","volume":"33","author":"Holaj","year":"2015","journal-title":"J Hypertens"},{"issue":"22","key":"2026030420412970400_lvag035-B7","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"2026030420412970400_lvag035-B8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2026030420412970400_lvag035-B9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J Hypertens"},{"issue":"2","key":"2026030420412970400_lvag035-B10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"2026030420412970400_lvag035-B11","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026030420412970400_lvag035-B12","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026030420412970400_lvag035-B13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronism as a risk factor for vertebral fracture","volume":"102","author":"Notsu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026030420412970400_lvag035-B14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"2026030420412970400_lvag035-B15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"5","key":"2026030420412970400_lvag035-B16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"issue":"3","key":"2026030420412970400_lvag035-B17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026030420412970400_lvag035-B18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2026030420412970400_lvag035-B19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"2026030420412970400_lvag035-B20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596\/-\/DC1","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"2026030420412970400_lvag035-B21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-21-0836","article-title":"Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments","volume":"186","author":"Wu","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026030420412970400_lvag035-B22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2026030420412970400_lvag035-B23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"issue":"1","key":"2026030420412970400_lvag035-B24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"2026030420412970400_lvag035-B25","author":"WHO Collaborating Centre for Drug Statistics Methodology"},{"issue":"2","key":"2026030420412970400_lvag035-B26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/HYPERTENSIONAHA.117.09078","article-title":"Rapid screening of primary aldosteronism by a novel chemiluminescent immunoassay","volume":"70","author":"Morimoto","year":"2017","journal-title":"Hypertension"},{"issue":"6","key":"2026030420412970400_lvag035-B27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from Serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"2026030420412970400_lvag035-B28","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMra1215672","article-title":"Integration of acid-base and electrolyte disorders","volume":"371","author":"Seifter","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"2026030420412970400_lvag035-B29","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026030420412970400_lvag035-B30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/jhh.2010.65","article-title":"The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism","volume":"24","author":"\u0160oml\u00f3ov\u00e1","year":"2010","journal-title":"J Hum Hypertens"},{"issue":"2","key":"2026030420412970400_lvag035-B31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cen.12981","article-title":"Factors affecting parathyroid hormone levels in different types of primary aldosteronism","volume":"85","author":"Jiang","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026030420412970400_lvag035-B32","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026030420412970400_lvag035-B33","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","article-title":"Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism","volume":"37","author":"Katabami","year":"2019","journal-title":"J Hypertens"},{"issue":"1","key":"2026030420412970400_lvag035-B34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0895-7061(97)00366-X","article-title":"Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension","volume":"11","author":"Rossi","year":"1998","journal-title":"Am J Hypertens"},{"issue":"11","key":"2026030420412970400_lvag035-B35","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","volume":"24","author":"Ceccoli","year":"2013","journal-title":"Osteoporos Int"},{"issue":"2","key":"2026030420412970400_lvag035-B36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","article-title":"Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"issue":"October","key":"2026030420412970400_lvag035-B37","doi-asserted-by":"publisher","first-page":"1027841","DOI":"10.3389\/fendo.2022.1027841","article-title":"Bone and mineral metabolism in patients with primary aldosteronism: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"9","key":"2026030420412970400_lvag035-B38","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1210\/jc.2019-00143","article-title":"PTH modulation by aldosterone and angiotensin II is blunted in hyperaldosteronism and rescued by adrenalectomy","volume":"104","author":"Lenzini","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026030420412970400_lvag035-B39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/a-1027-6472","article-title":"Primary and secondary hyperparathyroidism in patients with primary aldosteronism\u2014findings from the German Conn's registry","volume":"128","author":"Asbach","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"2026030420412970400_lvag035-B40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/08860220802060471","article-title":"Diurnal rhythm of urinary calcium excretion in adults","volume":"30","author":"Topal","year":"2008","journal-title":"Ren Fail"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag035\/67024481\/lvag035.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/2\/275\/67024481\/lvag035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/2\/275\/67024481\/lvag035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:41:34Z","timestamp":1772674894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/2\/275\/8493227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag035","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,2]]}}}